Literature DB >> 29595233

Is new better than tried and tested? Topical atopic dermatitis treatment in context.

K Abuabara1, C Flohr2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29595233      PMCID： PMC6214668          DOI： 10.1111/bjd.16316

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  11 in total

1.  Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

Authors:  Andrew Blauvelt; Marjolein de Bruin-Weller; Melinda Gooderham; Jennifer C Cather; Jamie Weisman; David Pariser; Eric L Simpson; Kim A Papp; H Chih-Ho Hong; Diana Rubel; Peter Foley; Errol Prens; Christopher E M Griffiths; Takafumi Etoh; Pedro Herranz Pinto; Ramon M Pujol; Jacek C Szepietowski; Karel Ettler; Lajos Kemény; Xiaoping Zhu; Bolanle Akinlade; Thomas Hultsch; Vera Mastey; Abhijit Gadkari; Laurent Eckert; Nikhil Amin; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos; Brad Shumel
Journal:  Lancet       Date:  2017-05-04       Impact factor: 79.321

2.  Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Authors:  Lawrence F Eichenfield; Anne W Lucky; Mark Boguniewicz; Richard G B Langley; Robert Cherill; Katharine Marshall; Christopher Bush; Michael Graeber
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

3.  Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

Authors:  Amy S Paller; Wynnis L Tom; Mark G Lebwohl; Robin L Blumenthal; Mark Boguniewicz; Robert S Call; Lawrence F Eichenfield; Douglass W Forsha; William C Rees; Eric L Simpson; Mary C Spellman; Linda F Stein Gold; Andrea L Zaenglein; Matilda H Hughes; Lee T Zane; Adelaide A Hebert
Journal:  J Am Acad Dermatol       Date:  2016-07-11       Impact factor: 11.527

4.  Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.

Authors:  Lawrence F Eichenfield; Robert S Call; Douglass W Forsha; Joseph Fowler; Adelaide A Hebert; Mary Spellman; Linda F Stein Gold; Merrie Van Syoc; Lee T Zane; Eduardo Tschen
Journal:  J Am Acad Dermatol       Date:  2017-08-18       Impact factor: 11.527

Review 5.  Atopic dermatitis.

Authors:  Stephan Weidinger; Natalija Novak
Journal:  Lancet       Date:  2015-09-13       Impact factor: 79.321

Review 6.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

7.  A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.

Authors:  M Boguniewicz; V C Fiedler; S Raimer; I D Lawrence; D Y Leung; J M Hanifin
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

8.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Authors:  Lisa A Beck; Diamant Thaçi; Jennifer D Hamilton; Neil M Graham; Thomas Bieber; Ross Rocklin; Jeffrey E Ming; Haobo Ren; Richard Kao; Eric Simpson; Marius Ardeleanu; Steven P Weinstein; Gianluca Pirozzi; Emma Guttman-Yassky; Mayte Suárez-Fariñas; Melissa D Hager; Neil Stahl; George D Yancopoulos; Allen R Radin
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

Review 9.  Therapeutic pipeline for atopic dermatitis: End of the drought?

Authors:  Amy S Paller; Kenji Kabashima; Thomas Bieber
Journal:  J Allergy Clin Immunol       Date:  2017-09       Impact factor: 10.793

10.  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Authors:  Robert Sidbury; Dawn M Davis; David E Cohen; Kelly M Cordoro; Timothy G Berger; James N Bergman; Sarah L Chamlin; Kevin D Cooper; Steven R Feldman; Jon M Hanifin; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Eric L Simpson; Wynnis L Tom; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Lawrence F Eichenfield
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527
View more
  1 in total

Review 1.  Therapeutic New Era for Atopic Dermatitis: Part 2. Small Molecules.

Authors:  Jiyoung Ahn; Yusung Choi; Eric Lawrence Simpson
Journal:  Ann Dermatol       Date:  2021-03-08       Impact factor: 1.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.